CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION

致癌物和染色质结构与功能

基本信息

  • 批准号:
    3166826
  • 负责人:
  • 金额:
    $ 17.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1979
  • 资助国家:
    美国
  • 起止时间:
    1979-06-01 至 1995-04-30
  • 项目状态:
    已结题

项目摘要

The poly ADP-ribosylation modification of nuclear proteins is the initial cellular response to DNA damage caused by chemicals. Poly(ADP-ribose) polymerase (PADPRP) catalytic activity is absolutely dependent upon DNA and its activity is directly correlated with the number of strand breaks in DNA. Thus, when cells, are exposed to chemical carcinogens, there is an immediate drop in cellular NAD and concomitant rapid and transient increase in poly ADP-ribosylated nuclear proteins. Recent progress on this project involved the cloning, sequencing, and hyperexpression of transfected genes for this enzyme in both human and murine systems. Preliminary data using transient transfection indicated that cells hyperexpressing PADPRP have increased rates of DNA repair. We also were able to map the precise chromosomal loci for this gene in both human and mouse. During the renewal period, we intent to utilize the molecular and biochemical data obtained to better clarify and characterize the role of ADP-ribosylation in DNA repair mechanisms. Methods in Aim I utilize a variety of molecular approaches including antisense and ribozyme expression, to experimentally modulate ADP-ribosylation potential in cells subjected to DNA strand breaks and assess the effects of this by utilizing new methods for precisely measuring preferential gene repair and recombinase activity using novel plasmid assays. Nuclear targets for ADP ribosylation are the focus of Aim II. The new molecular information will be used here to relate structure of PADPRP (and its nuclear protein acceptors) to function. For example, c-fos is a nuclear acceptor for PADPRP and also transcriptionally activated by strand- breaking chemicals. PADPRP activity modulated by antisense will be used to address the biological function of the PADPRP of fos, and as an example of approaches to be used for other nuclear protein acceptors during the renewal period.
核蛋白的聚adp核糖基化修饰是最初的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK E SMULSON其他文献

MARK E SMULSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK E SMULSON', 18)}}的其他基金

HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
  • 批准号:
    2086109
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
  • 批准号:
    3163723
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
致癌物和染色质结构与功能
  • 批准号:
    6192920
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
致癌物和染色质结构与功能
  • 批准号:
    2087361
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
致癌物和染色质结构与功能
  • 批准号:
    2653960
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
  • 批准号:
    3163724
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
  • 批准号:
    3163721
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
  • 批准号:
    3163718
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
致癌物和染色质结构与功能
  • 批准号:
    3166825
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
致癌物和染色质结构与功能
  • 批准号:
    6375614
  • 财政年份:
    1979
  • 资助金额:
    $ 17.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了